Puma Biotechnology stock could quadruple, says Jim Cramer
Puma Biotechnology, Inc.'s (NASDAQ:PBYI) US$24m market value fall may be overlooked by institutional investors after a year of 1.6% returns - Simply Wall St News
Loss-Making Puma Biotechnology, Inc. (NASDAQ:PBYI) Set To Breakeven - Simply Wall St News
SEC charges former Puma biotech exec with $1.1 million in insider trading
Supernus, Puma Among 5 Big Biotech Stock Winners, Losers Monday | Stock News & Stock Market Analysis - IBD
Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma
Puma Biotechnology Reports Fourth Quarter and Full Year Financial Results | Business Wire
Here's Why Puma Biotechnology Tumbled Today | The Motley Fool
Puma Biotech agrees to pay investors $54.2 mln in fraud case | Reuters